PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology, All India Institute of Medical Sciences, Gorakhpur, UP, India.\', \'Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, UP, India.\', \'Department of Internal Medicine, Institute of Post Graduate Medical Education and Research, Kolkata, WB, India.\', \'Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.\', \'Department of Biochemistry and Central Research Cell, Maharishi Markandeshwar (deemed to be) University, Mullana, Ambala, Haryana, India. Electronic address: profschakrabarti95@gmail.com.\', \'Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, UP, India. Electronic address: sankha.geriatrics@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0014-2999(20)30637-310.1016/j.ejphar.2020.173545
?:doi
?:hasPublicationType
?:journal
  • European journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32926917
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.057
?:rankingScore_hIndex
  • 161
?:title
  • Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32926917>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32926917>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all